LOADING
Comparing Microsoft Corporation (MSFT) and Merck & Company (MRK) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MSFT | MRK |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $3.22T | $279.1B |
| P/E Ratio | 27.1 | 15.5 |
| Forward P/E | 22.1 | 22.0 |
| PEG Ratio | 1.34 | 3.44 |
| EPS | $15.97 | $7.28 |
| Revenue Growth (YoY) | 16.7% | 5.0% |
| Profit Margin | 39.0% | 28.1% |
| Return on Equity | 34.4% | 36.9% |
| Dividend Yield | 0.82% | 2.88% |
| Beta | 1.11 | 0.28 |
| 52-Week High | $552.24 | $124.22 |
| 52-Week Low | $356.28 | $70.74 |
| Volume | -- | -- |
Microsoft Corporation is the larger company by market capitalization. Merck & Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company offers a higher dividend yield for income investors. Microsoft Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.